Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of three meningococcal B vaccine strategies in asplenic adults
2019-000924-17Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2019
- Countries
- 1
01
Overview
Phase 3, randomised trial of meningococcal group B vaccine in meningococcal disease (3 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Proportion of responders (primary endpoint). Started Jun 2019; status: active.
02
Drugs
meningococcal group B vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2019-000924-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000924-17.